BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18323584)

  • 21. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
    Galderisi M; de Divitiis O
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
    Uchaipichat V; Koanantakul B; Suthisisang C
    J Med Assoc Thai; 2008 Sep; 91(9):1468-77. PubMed ID: 18843880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibitors influence left ventricular mass and function independently of the antihypertensive effect.
    Grandi AM; Laurita E; Solbiati F; Marchesi C; Maresca AM; Nicolini E; Guasti L; Venco A
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):207-11. PubMed ID: 17110802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of ramipril on metabolic, renal and cardiac function in hypertension and type II diabetes mellitus].
    Vítovec J; Spinar J
    Vnitr Lek; 1998 Jun; 44(6):336-41. PubMed ID: 9820056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
    Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity.
    Harris KM; Aeppli DM; Carey CF
    Am Heart J; 2005 Nov; 150(5):1106. PubMed ID: 16291006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Israeli trial with cilazapril (Vasocase) for the treatment of hypertension--summary of the care of 413 patients in a community health setting].
    Zimlichman R
    Harefuah; 2000 Mar; 138(5):345-50, 424. PubMed ID: 10883128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ramipril in the treatment of moderate to moderately severe hypertension. A multicenter open study].
    Spinar J; Vítovec J
    Vnitr Lek; 1998 Jun; 44(6):332-5. PubMed ID: 9820055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study.
    Palmieri V; Bella JN; Gerdts E; Wachtell K; Papademetriou V; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2008 Jun; 21(6):701-7. PubMed ID: 18437127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Different left ventricular geometric patterns and ambulatory pulse pressures in essential hypertensive patients].
    Cao Y; Zhao SP; Luo L; Li QH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):441-4. PubMed ID: 16134600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: a randomized cross-over study.
    Brili S; Tousoulis D; Antoniades C; Vasiliadou C; Karali M; Papageorgiou N; Ioakeimidis N; Marinou K; Stefanadi E; Stefanadis C
    J Am Coll Cardiol; 2008 Feb; 51(7):742-9. PubMed ID: 18279739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload.
    Müller P; Kazakov A; Jagoda P; Semenov A; Böhm M; Laufs U
    Cardiovasc Res; 2009 Jul; 83(1):106-14. PubMed ID: 19380417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
    Flammer AJ; Sudano I; Hermann F; Gay S; Forster A; Neidhart M; Künzler P; Enseleit F; Périat D; Hermann M; Nussberger J; Luscher TF; Corti R; Noll G; Ruschitzka F
    Circulation; 2008 Apr; 117(17):2262-9. PubMed ID: 18427133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.